PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma

NCT01961804 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

202

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coagulation; Intravascular
Craniocerebral Trauma
Haemorrhage

Interventions

DRUG: Reversion

Sponsor

University Hospital, Angers